Featured
-
-
Letter |
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
Innate lymphoid cells increase the growth of mouse intestinal organoids via IL-22 production; recombinant IL-22 promotes growth of both mouse and human organoids, and promotes mouse intestinal stem cell (ISC) expansion and ISC-driven organoid growth via a STAT3-dependent pathway and independently of Paneth cells; IL-22 treatment in vivo enhances the recovery of ISCs from intestinal injury.
- Caroline A. Lindemans
- , Marco Calafiore
- & Alan M. Hanash
-
Letter |
Direct measurement of local oxygen concentration in the bone marrow of live animals
Here, using two-photon phosphorescence lifetime microscopy, the local oxygen tension in the bone marrow of live mice is found to be quite low, with spatiotemporal variations depending on the blood vessel type, distance to the endosteum, and changes in cellularity after stress.
- Joel A. Spencer
- , Francesca Ferraro
- & Charles P. Lin
-
News |
Bone-marrow transplant reverses Rett syndrome in mice
Rare autism spectrum disorder is partially caused by faulty immune cells in the brain.
- Ewen Callaway
-
News |
Drug-free organ transplants without tissue matching
Bone-marrow transfer could end the need for lifelong immunosupression.
- Elie Dolgin
-
Letter |
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche
- Joji Fujisaki
- , Juwell Wu
- & Charles P. Lin
-
News |
Key to psychological disorder may lie in the immune system
Bone-marrow transplants cure obsessive-compulsive behaviour in mice.
- Janelle Weaver
-
Article |
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
GNF-2 is a recently discovered, selective allosteric Bcr–Abl inhibitor. Solution NMR, X-ray crystallography, mutagenesis and hydrogen exchange mass spectrometry are now used to show that GNF-2 binds to the myristate-binding site of Abl, leading to changes in the structural dynamics of the ATP-binding site. The results show that the combination of allosteric and ATP-competitive inhibitors can overcome resistance to either agent alone.
- Jianming Zhang
- , Francisco J. Adrián
- & Nathanael S. Gray